Biotech

All Articles

Galapagos stops CAR-T tissue treatment hearing over Parkinsonism situation

.Galapagos has actually stopped briefly application in a test of a BCMA-directed CAR-T cell treatmen...

James Wilson leaving behind Penn to release two brand new biotechs

.After much more than 30 years, genetics treatment pioneer James Wilson M.D., Ph.D., is leaving the ...

3 biotechs make an effort to beat the summertime warmth through dropping workers

.As biotechs attempt to switch a new web page in August, a minimum of 3 firms have dropped personnel...

venBio elevates $528M for fifth life sciences VC fund

.Professional financial backing firm venBio has actually raised an additional half a billion bucks t...

Otsuka pays out $800M for Jnana and its own clinical-stage PKU medication

.Otsuka Drug has actually picked up Boston-based Jnana Therapeutics for $800 million so the Eastern ...

FibroGen lays off 75% of US team as resource fails 2 more tests

.FibroGen is drastically reorganizing its own service, laying off 75% of its united state team as we...

Tracon wane full weeks after injectable PD-L1 prevention neglect

.Tracon Pharmaceuticals has actually determined to wane procedures full weeks after an injectable im...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is betting $400 million in biobucks that a bispecific antibody-drug conjugate (A...

Takeda takes $140M loss on neglected epilepsy medicine, touts FDA operate

.Our company already know that Takeda is actually expecting to locate a pathway to the FDA for epile...

VBI Vaccinations files for insolvency, looks for asset sale

.Immunology biotech VBI Injections is actually turning precariously near to the moment of truth, wit...